A perfect example is the evolution of the original All-on-4® treatment concept. New componentry significantly reduces chair time, while the introduction of updated zygomatic implants and an extended line of NobelSpeedy implants enable even more patients to benefit from this life-changing solution. Now, the Nobel Biocare portfolio can cater even for patients that were previously deemed untreatable.
Addressing an unmet patient need is the driving force behind the launch of the Trefoil system—a groundbreaking new option for the edentulous lower jaw. Its IP-protected framework with a unique fixation mechanism enables the fixed, definitive, full-arch restoration of the mandible on the day of surgery.
Using the market as a testing ground for innovations is not the Nobel Biocare way. Prior to launch, one-year preliminary results of a global multi-center already showed outstanding results for Trefoil patients.
Just as our dedication to restoring quality of life for edentulous patients endures, so too does our dedication to scientific rigor and providing evidence-based solutions.